☰

Katherine A. Collins, Ph.D. - Publications

Affiliations: 
Neurosciences Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
reconsolidation, reversal learning, inhibition of fear, fMRI, SCR
Tree Info Grants Similar researchers PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Iosifescu DV, Norton RJ, Tural U, Mischoulon D, Collins K, McDonald E, De Taboada L, Foster S, Cusin C, Yeung A, Clain A, Schoenfeld D, Hamblin MR, Cassano P. Very Low-Level Transcranial Photobiomodulation for Major Depressive Disorder: The ELATED-3 Multicenter, Randomized, Sham-Controlled Trial. The Journal of Clinical Psychiatry. 83. PMID 35950904 DOI: 10.4088/JCP.21m14226  0.305
2021 Collins KA, Eng GK, Tural Ü, Irvin MK, Iosifescu DV, Stern ER. Affective and somatic symptom clusters in depression and their relationship to treatment outcomes in the STAR*D sample. Journal of Affective Disorders. PMID 34952119 DOI: 10.1016/j.jad.2021.12.046  0.312
2021 Costi S, Morris LS, Collins A, Fernandez NF, Patel M, Xie H, Kim-Schulze S, Stern ER, Collins KA, Cathomas F, Parides MK, Whitton AE, Pizzagalli DA, Russo SJ, Murrough JW. Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia. Translational Psychiatry. 11: 565. PMID 34741019 DOI: 10.1038/s41398-021-01668-1  0.319
2020 Eng GK, Collins KA, Brown C, Ludlow M, Tobe RH, Iosifescu DV, Stern ER. Dimensions of interoception in obsessive-compulsive disorder. Journal of Obsessive-Compulsive and Related Disorders. 27. PMID 33194538 DOI: 10.1016/J.Jocrd.2020.100584  0.34
2020 Stern ER, Brown C, Ludlow M, Shahab R, Collins K, Lieval A, Tobe RH, Iosifescu DV, Burdick KE, Fleysher L. The buildup of an urge in obsessive-compulsive disorder: Behavioral and neuroimaging correlates. Human Brain Mapping. PMID 31916668 DOI: 10.1002/Hbm.24898  0.357
2020 Collins K, Brown C, Ludlow M, Eng GK, Tobe R, Iosifescu DV, Stern E. Identifying Subtypes of Sensory Symptoms in Obsessive-Compulsive Disorder Biological Psychiatry. 87: S402. DOI: 10.1016/J.Biopsych.2020.02.1027  0.309
2020 Murrough J, Costi S, Morris L, Collins A, Collins K, Whitton A, Pizzagalli D, Russo S. Dynamic Peripheral Immune Profiles and Neurocircuit Responses to Reward in Depression Biological Psychiatry. 87: S15-S16. DOI: 10.1016/J.Biopsych.2020.02.066  0.35
2019 Hoch MM, Doucet GE, Moser DA, Hee Lee W, Collins KA, Huryk KM, DeWilde KE, Fleysher L, Iosifescu DV, Murrough JW, Charney DS, Frangou S, Iacoviello BM. Initial Evidence for Brain Plasticity Following a Digital Therapeutic Intervention for Depression. Chronic Stress (Thousand Oaks, Calif.). 3: 2470547019877880. PMID 32440602 DOI: 10.1177/2470547019877880  0.35
2019 Costi S, Soleimani L, Glasgow A, Brallier J, Spivack J, Schwartz J, Levitch CF, Richards S, Hoch M, Wade E, Welch A, Collins KA, Feder A, Iosifescu DV, Charney DS, et al. Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30858518 DOI: 10.1038/S41386-019-0365-0  0.443
2018 Mathew SJ, Wilkinson ST, Altinay M, Asghar-Ali A, Chang LC, Collins KA, Dale RM, Hu B, Krishnan K, Kellner CH, Malone DA, Murrough JW, Ostroff RB, Sanacora G, Shao M, et al. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol. Contemporary Clinical Trials. PMID 30572160 DOI: 10.1016/J.Cct.2018.12.009  0.428
2018 Brown C, Shahab R, Collins K, Fleysher L, Goodman WK, Burdick KE, Stern ER. Functional neural mechanisms of sensory phenomena in obsessive-compulsive disorder. Journal of Psychiatric Research. 109: 68-75. PMID 30508745 DOI: 10.1016/J.Jpsychires.2018.11.018  0.322
2018 Tan A, Costi S, Morris LS, Van Dam NT, Kautz M, Whitton AE, Friedman AK, Collins KA, Ahle G, Chadha N, Do B, Pizzagalli DA, Iosifescu DV, Nestler EJ, Han MH, et al. Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder. Molecular Psychiatry. PMID 30385872 DOI: 10.1038/S41380-018-0283-2  0.475
2018 Murrough JW, Huryk KM, Mao X, Iacoviello B, Collins K, Nierenberg AA, Kang G, Shungu DC, Iosifescu DV. A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo. Journal of Affective Disorders. 230: 56-64. PMID 29407539 DOI: 10.1016/J.Jad.2017.12.067  0.411
2018 Brown C, Shahab R, Collins K, Burdick K, Stern E. S21. Neural Mechanisms of Sensory Phenomena and Other Dimensional Symptoms in Obsessive-Compulsive Disorder Biological Psychiatry. 83: S354-S355. DOI: 10.1016/J.Biopsych.2018.02.912  0.31
2018 Hoch M, Collins KA, Doucet GE, Moser DA, Huryk KM, DeWilde KE, Fleysher L, Murrough JW, Frangou S, Iacoviello BM, Charney DS. T129. Brain Connectivity Changes Associated With a Cognitive-Emotional Training Intervention for Depression Biological Psychiatry. 83: S178. DOI: 10.1016/J.Biopsych.2018.02.465  0.339
2017 Sayed S, Van Dam NT, Horn SR, Kautz MM, Parides M, Costi S, Collins KA, Iacoviello B, Iosifescu DV, Mathé AA, Southwick SM, Feder A, Charney DS, Murrough JW. A randomized dose-ranging study of neuropeptide Y in patients with posttraumatic stress disorder. The International Journal of Neuropsychopharmacology. PMID 29186416 DOI: 10.1093/Ijnp/Pyx109  0.329
2017 Murrough JW, Wade E, Sayed S, Ahle G, Kiraly DD, Welch A, Collins KA, Soleimani L, Iosifescu DV, Charney DS. Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial. Journal of Affective Disorders. 218: 277-283. PMID 28478356 DOI: 10.1016/J.Jad.2017.04.072  0.453
2017 Murrough J, Sayed S, Van Dam N, Horn S, Kautz M, Parides M, Iacoviello B, Costi S, Collins K, Iosifescu D, Southwick S, Mathé A, Feder A, Charney D. 171. A Randomized Controlled Dose-Ranging Study of Intranasal Administration of Neuropeptide Y in Patients with Posttraumatic Stress Disorder Biological Psychiatry. 81: S71. DOI: 10.1016/J.Biopsych.2017.02.184  0.31
2016 Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, DeWilde KE, Wong E, Anticevic A, Tang CY, Iosifescu DV, Charney DS, Murrough JW. Ketamine Treatment and Global Brain Connectivity in Major Depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27604566 DOI: 10.1038/Npp.2016.186  0.434
2016 Murrough JW, Abdallah CG, Anticevic A, Collins KA, Geha P, Averill LA, Schwartz J, DeWilde KE, Averill C, Jia-Wei Yang G, Wong E, Tang CY, Krystal JH, Iosifescu DV, Charney DS. Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder. Human Brain Mapping. PMID 27144347 DOI: 10.1002/Hbm.23235  0.439
2016 Costi S, Collins K, Davidson M, Iosifescu DV. Using Placebo Response to Pain as a Predictor of Placebo Response in Mood Disorders Current Behavioral Neuroscience Reports. 3: 360-367. DOI: 10.1007/S40473-016-0092-3  0.448
2015 Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychological Medicine. 1-10. PMID 26266877 DOI: 10.1017/S0033291715001506  0.37
2015 Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ, Wong E, Tang CY, Charney DS, Iosifescu DV. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. Translational Psychiatry. 5: e509. PMID 25689570 DOI: 10.1038/Tp.2015.10  0.438
2015 Costi S, Hodes G, Schwartz J, Horn S, Collins K, Iosifescu D, Russo S, Murrough J. P.1.f.020 Association between peripheral interleukin 6 and brain response to positive stimuli in a depressive spectrum European Neuropsychopharmacology. 25: S235-S236. DOI: 10.1016/S0924-977X(15)30257-1  0.349
2014 Collins KA, Mendelsohn A, Cain CK, Schiller D. Taking action in the face of threat: neural synchronization predicts adaptive coping. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14733-8. PMID 25355225 DOI: 10.1523/Jneurosci.2152-14.2014  0.497
2014 Iacoviello BM, Wu G, Alvarez E, Huryk K, Collins KA, Murrough JW, Iosifescu DV, Charney DS. Cognitive-emotional training as an intervention for major depressive disorder. Depression and Anxiety. 31: 699-706. PMID 24753225 DOI: 10.1002/Da.22266  0.36
2013 Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology. PMID 24022236 DOI: 10.1007/S00213-013-3255-X  0.415
2013 Collins KA, Schiller D. What can fear and reward learning teach us about depression? Current Topics in Behavioral Neurosciences. 14: 223-42. PMID 23299804 DOI: 10.1007/7854_2012_236  0.561
2013 Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biological Psychiatry. 74: 250-6. PMID 22840761 DOI: 10.1016/J.Biopsych.2012.06.022  0.415
2011 Feder A, Skipper J, Blair JR, Buchholz K, Mathew SJ, Schwarz M, Doucette JT, Alonso A, Collins KA, Neumeister A, Charney DS. Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression. Biological Psychiatry. 69: 804-7. PMID 21377656 DOI: 10.1016/J.Biopsych.2010.12.033  0.399
2011 Murrough JW, Gallo JM, Collins KA, Aan Het Rot M, Charney DS. Reply to: Dose- and exposure-response to ketamine in depression Biological Psychiatry. 70: e11-e12. DOI: 10.1016/J.Biopsych.2011.02.018  0.364
2010 Murrough JW, Mao X, Collins KA, Kelly C, Andrade G, Nestadt P, Levine SM, Mathew SJ, Shungu DC. Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. Nmr in Biomedicine. 23: 643-50. PMID 20661876 DOI: 10.1002/Nbm.1512  0.358
2010 aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biological Psychiatry. 67: 139-45. PMID 19897179 DOI: 10.1016/J.Biopsych.2009.08.038  0.396
2010 Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 71-82. PMID 19288975 DOI: 10.1017/S1461145709000169  0.393
2009 aan het Rot M, Collins KA, Fitterling HL. Physical exercise and depression. The Mount Sinai Journal of Medicine, New York. 76: 204-14. PMID 19306383 DOI: 10.1002/Msj.20094  0.32
2009 Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biological Psychiatry. 65: 792-800. PMID 19058788 DOI: 10.1016/J.Biopsych.2008.10.025  0.381
2009 Dozois DJA, Seeds PM, Collins KA. Transdiagnostic approaches to the prevention of depression and anxiety Journal of Cognitive Psychotherapy. 23: 44-59. DOI: 10.1891/0889-8391.23.1.44  0.305
2008 Dumitriu D, Collins K, Alterman R, Mathew SJ. Neurostimulatory therapeutics in management of treatment-resistant depression with focus on deep brain stimulation Mount Sinai Journal of Medicine. 75: 263-275. PMID 18704979 DOI: 10.1002/Msj.20044  0.4
2004 Collins KA, Westra HA, Dozois DJ, Burns DD. Gaps in accessing treatment for anxiety and depression: challenges for the delivery of care. Clinical Psychology Review. 24: 583-616. PMID 15325746 DOI: 10.1016/j.cpr.2004.06.001  0.326
Show low-probability matches.